ID: ALA461518

Max Phase: Preclinical

Molecular Formula: C10H13N3O

Molecular Weight: 191.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N/C(=N\O)N1CCc2ccccc2C1

Standard InChI:  InChI=1S/C10H13N3O/c11-10(12-14)13-6-5-8-3-1-2-4-9(8)7-13/h1-4,14H,5-7H2,(H2,11,12)

Standard InChI Key:  XTTAIKKVDJISCN-UHFFFAOYSA-N

Associated Targets(Human)

Mitochondrial amidoxime-reducing component 1 51 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 191.23Molecular Weight (Monoisotopic): 191.1059AlogP: 0.75#Rotatable Bonds: 0
Polar Surface Area: 61.85Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.35CX Basic pKa: 7.63CX LogP: 1.06CX LogD: 0.64
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.28Np Likeness Score: -0.77

References

1. Gruenewald S, Wahl B, Bittner F, Hungeling H, Kanzow S, Kotthaus J, Schwering U, Mendel RR, Clement B..  (2008)  The fourth molybdenum containing enzyme mARC: cloning and involvement in the activation of N-hydroxylated prodrugs.,  51  (24): [PMID:19053771] [10.1021/jm8010417]

Source